COVID-19 vaccines: breaking record times to first-in-human trials

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

A novel coronavirus outbreak of global health concern

Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700 · see citing works

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Jänke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,143 · see citing works

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

Duffy, M. R., Chen, T.-H., Hancock, W. T., Powers, A. M., Kool, J. L., Lanciotti, R. S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805715 · Cited by 3,130 · see citing works

Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak

Wilder-Smith, A., & Freedman, D. O. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa020 · Cited by 2,727 · see citing works

Zika Virus (I). Isolations and serological specificity

Dick, G. W. A., Kitchen, S. F., & Haddow, A. J. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90042-4 · Cited by 2,698 · see citing works

Research on Dengue during World War II

Sabin, A. B. (1952) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1952.1.30 · Cited by 955 · see citing works

Zika virus (II). Pathogenicity and physical properties

Dick, G. W. A. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90043-6 · Cited by 690 · see citing works

The Newala epidemic: III. The virus: isolation, pathogenic properties and relationship to the epidemic

Ross, R. W. (1956) · Journal of Hygiene · doi:10.1017/s0022172400044442 · Cited by 650 · see citing works

Lassa Fever, a New Virus Disease of Man from West Africa

Frame, J. D., Baldwin, J. M., Gocke, D. J., & Troup, J. M. (1970) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1970.19.670 · Cited by 548 · see citing works

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Agnandji, S. T., Huttner, A. C., Zinser, M. E., Njuguna, P., Dahlke, C., Fernandes, J. F., Yerly, S., Dayer, J.-A., Krähling, V., Kasonta, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502924 · Cited by 415 · see citing works

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Regules, J. A., Beigel, J. H., Paolino, K. M., Voell, J., Castellano, A. R., Hu, Z., Muñoz, P., Moon, J. E., Ruck, R. C., Bennett, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414216 · Cited by 388 · see citing works

Seroprevalence of Chikungunya Virus (CHIKV) Infection on Lamu Island, Kenya, October 2004

Sergon, K., Njuguna, C. K., Kalani, R., Ofula, V., Onyango, C. O., Konongoi, S. L., Bedno, S. A., Burke, H., Dumilla, A. M., Konde, J., et al. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.333 · Cited by 329 · see citing works

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Gaudinski, M. R., Houser, K. V., Morabito, K. M., Hu, Z., Yamshchikov, G. V., Rothwell, R. S., Berkowitz, N. M., Mendoza, F. H., Saunders, J. G., Novik, L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)33105-7 · Cited by 302 · see citing works

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

Chang, L.-J., Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G. V., Sarwar, U. N., Hu, Z., Enama, M. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61185-5 · Cited by 257 · see citing works

ISOLATION OF MARBURG-LIKE VIRUS FROM A CASE OF HÆMORRHAGIC FEVER IN ZAIRE

Pattyn, S. R., van der Groen, G., Jacob, W., Piot, P., & Courteille, G. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92002-5 · Cited by 196 · see citing works

Production and Evaluation of a Formalin-Killed Chikungunya Vaccine

Harrison, V. R., Eckels, K. H., Bartelloni, P. J., & Hampton, C. (1971) · The Journal of Immunology · doi:10.4049/jimmunol.107.3.643 · Cited by 154 · see citing works

Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations--clinical notes.

Simpson, D. I. H., Knight, E. M., Courtois, G., Williams, M., Weinbren, M. P., & Kibukamusoke, J. W. (1967) · PubMed · Cited by 114 · see citing works

Experimental Inverstigations Regarding the Etiology of Dengue Fever

Ashburn, P. M., & Craig, C. F. (1907) · The Journal of Infectious Diseases · doi:10.1093/infdis/4.3.440 · Cited by 97 · see citing works

Pneumonia causes panic in Guangdong province

Rosling, L., & Rosling, M. (2003) · BMJ · doi:10.1136/bmj.326.7386.416 · Cited by 61 · see citing works

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane

Vitelli, A., Folgori, A., Scarselli, E., Colloca, S., Capone, S., & Nicosia, A. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1394842 · Cited by 48 · see citing works

COMMENTARY: Ashburn PM, Craig CF. Experimental Investigations Regarding the Etiology of Dengue. J Infect Dis 1907; 4:440–75.

Gubler, D. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/383418 · Cited by 31 · see citing works

Developing effective vaccines: Cues from natural infection

Bhurani, V., Mohankrishnan, A., Morrot, A., & Dalai, S. K. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1471479 · Cited by 16 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

Behavioural nudges increase COVID-19 vaccinations

Dai, H., Saccardo, S., Han, M. A., Roh, L., Raja, N., Vangala, S., Modi, H., Pandya, S., Sloyan, M., & Croymans, D. M. (2021) · Nature · doi:10.1038/s41586-021-03843-2 · Cited by 462 · see citing works

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

Chung, Y. H., Beiss, V., Fiering, S., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 341 · see citing works

AI bias: exploring discriminatory algorithmic decision-making models and the application of possible machine-centric solutions adapted from the pharmaceutical industry

Belenguer, L. (2022) · AI and Ethics · doi:10.1007/s43681-022-00138-8 · Cited by 289 · see citing works

An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study

Yang, Z., Bogdan, P., & Nazarian, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81749-9 · Cited by 271 · see citing works

Vaccines for COVID-19

Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13517 · Cited by 222 · see citing works

T‐cell responses and therapies against SARS‐CoV‐2 infection

Toor, S. M., Saleh, R., Nair, V. S., Taha, R. Z., & Elkord, E. (2020) · Immunology · doi:10.1111/imm.13262 · Cited by 204 · see citing works

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

Funk, C. D., Laferrière, C. A., & Ardakani, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00937 · Cited by 200 · see citing works

Emerging Technologies for Use in the Study, Diagnosis, and Treatment of Patients with COVID-19

Tsikala Vafea, M., Atalla, E., Georgakas, J., Shehadeh, F., Mylona, E. K., Kalligeros, M., & Mylonakis, E. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00629-w · Cited by 153 · see citing works

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Tiwari, R., Yatoo, M. I., Patel, S. K., Pathak, M., Malik, Y. S., Dhama, K., Singh, K. P., et al. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00384-w · Cited by 154 · see citing works

The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy

Mohapatra, R. K., Pintilie, L., Kandi, V., Sarangi, A. K., Das, D., Sahu, R., & Perekhoda, L. O. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13761 · Cited by 128 · see citing works

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times

Montero, C. G., Fraile‐Μartinez, O., Bravo, C., Torres‐Carranza, D., Sánchez‐Trujillo, L., Gomez-Lahoz, A. M., Guijarro, L. G., García‐Honduvilla, N., Asúnsolo, Á., Buján, J., et al. (2021) · Vaccines · doi:10.3390/vaccines9050433 · Cited by 109 · see citing works

Smartphone apps in the COVID-19 pandemic

Pandit, J. A., Radin, J. M., Quer, G., & Topol, E. J. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01350-x · Cited by 101 · see citing works

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond

Dhama, K., Patel, S. K., Kumar, R., Rana, J., Yatoo, M. I., Kumar, A., Tiwari, R., Dhama, J., Natesan, S., Singh, R. P., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.574198 · Cited by 98 · see citing works

The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines

Machado, B. A. S., Hodel, K. V. S., Fonseca, L. M. D. S., Pires, V. C., Mascarenhas, L. A. B., Andrade, L. P. C. D. S., Moret, M. A., & Badaró, R. J. D. S. (2022) · Vaccines · doi:10.3390/vaccines10040591 · Cited by 75 · see citing works

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development

Alturki, S. O., Alturki, S. O., Connors, J. R., Cusimano, G. M., Kutzler, M. A., Izmirly, A. M., & Haddad, E. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01880 · Cited by 73 · see citing works

Next-Generation Sequencing for Confronting Virus Pandemics

Quer, J., Colomer‐Castell, S., de Campos, C. F., Andrés, C., Piñana, M., Cortese, M. F., Gónzalez‐Sánchez, A., García‐Cehic, D., Ibañez‐Lligoña, M., Pumarola, T., et al. (2022) · Viruses · doi:10.3390/v14030600 · Cited by 74 · see citing works

An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic

Jamwal, S., Gautam, A., Elsworth, J. D., Kumar, M., Chawla, R., & Kumar, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118105 · Cited by 71 · see citing works

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Zhang, Z., Shen, Q., & Chang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843928 · Cited by 69 · see citing works

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)

Vivarelli, S., Falzone, L., Torino, F., Scandurra, G., Russo, G. L., Bordonaro, R., Pappalardo, F., Spandidos, D. A., Raciti, G., & Libra, M. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5159 · Cited by 64 · see citing works

Recent advances in immunotherapies against infectious diseases

Ramamurthy, D., Nundalall, T., Cingo, S., Mungra, N., Karaan, M., Naran, K., & Barth, S. (2020) · Immunotherapy Advances · doi:10.1093/immadv/ltaa007 · Cited by 63 · see citing works

Predicting COVID-19 Vaccination Intention: The Determinants of Vaccine Hesitancy

Fernandes, N., Costa, D., Costa, D., Keating, J., & Arantes, J. (2021) · Vaccines · doi:10.3390/vaccines9101161 · Cited by 61 · see citing works

Assessment of Knowledge, Perception and Readiness of Nigerians to Participate in the COVID-19 Vaccine Trial

Enitan, S. S., Oyekale, A. O., Akele, R. Y., Olawuyi, K. A., Olabisi, E. O., Nwankiti, A. J., Adejumo, E., & Enitan, C. B. (2020) · International Journal of Vaccines and Immunization · doi:10.16966/2470-9948.123 · Cited by 58 · see citing works

Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives

Vivekanandhan, K., Poornima, S., Barabadi, H., Arumugam, V., Raj, D. D. R. D. P., Manikandan, S., Subbaiya, R., Anand, K., Pandi, B., Chandrasekaran, B., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.604447 · Cited by 58 · see citing works

Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments

Defendi, H. G. T., Madeira, L. D. S., & Borschiver, S. (2021) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-021-09535-8 · Cited by 57 · see citing works

Pandemics are catalysts of scientific novelty: Evidence from COVID ‐19

Liu, M., Bu, Y., Chen, C., Xu, J., Li, D., Leng, Y., Freeman, R. B., Meyer, E. T., Yoon, W., Sung, M., et al. (2021) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.24612 · Cited by 62 · see citing works

Subunit vaccines for Acinetobacter baumannii

Yang, N., Jin, X., Zhu, C., Gao, F., Weng, Z., Du, X., & Feng, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1088130 · Cited by 53 · see citing works

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

Behera, P., Singh, A. K., Subba, S. H., Arjun, M. C., Sahu, D. P., Chandanshive, P. D., Pradhan, S. K., Parida, S. P., Mishra, A., Patro, B. K., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2034456 · Cited by 51 · see citing works

Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines

Dhawan, M. K., Rabaan, A. A., Fawarah, M. M., Almuthree, S. A., Alsubki, R. A., Alfaraj, A. H., Mashraqi, M. M., Alshamrani, S., Abduljabbar, W. A., Alwashmi, A. S. S., et al. (2023) · Vaccines · doi:10.3390/vaccines11010101 · Cited by 45 · see citing works

Rethinking Clinical Trials Reform During the COVID-19 Pandemic

Nabhan, C., Choueiri, T. K., & Mato, A. R. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3142 · Cited by 41 · see citing works

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

Inchingolo, A. D., Dipalma, G., Inchingolo, A. M., Malcangi, G., Santacroce, L., D’Oria, M. T., Isacco, C. G., Bordea, I. R., Candrea, S., Scarano, A., et al. (2021) · Antioxidants · doi:10.3390/antiox10060881 · Cited by 40 · see citing works

Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years

Tan, Y. C., & Lahiri, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900509 · Cited by 40 · see citing works

The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers

Elbehiry, A., Marzouk, E., Moussa, I. M., Mushayt, Y., Algarni, A. A., Alrashed, O., Alghamdi, K., Almutairi, N. M., Anagreyyah, S. A., Alzahrani, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11071171 · Cited by 37 · see citing works

COVID‐19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives

Gupta, A., Kumar, S., Kumar, R., Choudhary, A. K., Kumari, K., Singh, P., & Kumar, V. (2020) · ChemistrySelect · doi:10.1002/slct.202001709 · Cited by 35 · see citing works

Chikungunya Virus: Priority Pathogen or Passing Trend?

Zurbia-Flores, G. M., Reyes‐Sandoval, A., & Kim, Y. C. (2023) · Vaccines · doi:10.3390/vaccines11030568 · Cited by 33 · see citing works

Human SARS-CoV-2 has evolved to increase U content and reduce genome size

Wang, Y. L., Chen, X., Yang, L., Yao, Q., & Chen, K. P. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.02.034 · Cited by 31 · see citing works

An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)

Bahrami, A. A., Azargoonjahromi, A., Sadraei, S., Aarabi, A., Payandeh, Z., & Rajabibazl, M. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00339-3 · Cited by 32 · see citing works

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Zurbia-Flores, G. M., Rollier, C. S., & Reyes‐Sandoval, A. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1895644 · Cited by 28 · see citing works

Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments

Akter, R., Rahman, M. H., Bhattacharya, T., Kaushik, D. K., Mittal, V., Parashar, J., Kumar, K., Kabir, M. T., & Tagde, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16809-8 · Cited by 28 · see citing works

Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccines

Malburet, C., Leclercq, L., Cotte, J., Thiebaud, J., Bazin, E., Garinot, M., & Cottet, H. (2022) · Gene Therapy · doi:10.1038/s41434-022-00370-1 · Cited by 29 · see citing works

Addressing the illegal wildlife trade in the European Union as a public health issue to draw decision makers attention

Halbwax, M. (2020) · Biological Conservation · doi:10.1016/j.biocon.2020.108798 · Cited by 25 · see citing works

Data-Driven and Technology-Enabled Trial Innovations Toward Decentralization of Clinical Trials: Opportunities and Considerations

Sehrawat, O., Noseworthy, P. A., Siontis, K. C., Haddad, T. C., Halamka, J. D., & Liu, H. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.02.003 · Cited by 25 · see citing works

COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice

Kataria, A., Yakubu, I., Winstead, R. J., Gowda, M., & Gupta, G. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001031 · Cited by 25 · see citing works

Immunotherapeutics for Covid-19 and post vaccination surveillance

Kumar, N. S. S., Chintagunta, A. D., Kumar, S., Roy, S., & Kumar, M. (2020) · 3 Biotech · doi:10.1007/s13205-020-02522-9 · Cited by 25 · see citing works

Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Sharma, G., Saha, R. P., & Lee, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e5 · Cited by 25 · see citing works

Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2

Cho, B. G., Gautam, S., Peng, W., Huang, Y., Goli, M., & Mechref, Y. S. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00323 · Cited by 25 · see citing works

The COVID-19 pandemic as a long-term school crisis: Impact, risk, resilience, and crisis management.

Nickerson, A. B., & Sulkowski, M. L. (2021) · School Psychology · doi:10.1037/spq0000470 · Cited by 24 · see citing works

FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses

Mekhail, K., Lee, M., Sugiyama, M. G., Astori, A., St‐Germain, J. R., Latreille, E., Khosraviani, N., Wei, K., Li, Z., Rini, J. M., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100256 · Cited by 25 · see citing works

Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations

Dzau, V., & Balatbat, C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32289-3 · Cited by 17 · see citing works

Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach

Rodríguez‐Frias, F., Quer, J., Tabernero, D., Cortese, M. F., García-García, S., Rando‐Segura, A., & Pumarola, T. (2021) · Microorganisms · doi:10.3390/microorganisms9122518 · Cited by 23 · see citing works

The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts

Khan, I., Ahmed, Z., Sarwar, A., Jamil, A. R., & Anwer, F. (2020) · Cureus · doi:10.7759/cureus.8871 · Cited by 22 · see citing works

Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines

Neto, A. R. D. S., de Carvalho, A. R. B., da Silva, M. D. F., Neta, M. M. R., Sena, I. V. D. O., Almeida, R. N., Filha, F. S. S. C., Silva, L. L. L. E., da Costa, G. R., Lira, I. M. D. S., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064796 · Cited by 20 · see citing works

Projecting the impact of Covid-19 variants and vaccination strategies in disease transmission using a multilayer network model in Costa Rica

García, Y. E., Mery, G., Vásquez, P., Calvo, J. G., Barboza, L. A., Rivas, T., & Sánchez, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-06236-1 · Cited by 17 · see citing works

Application of Optimal Control of Infectious Diseases in a Model-Free Scenario

Nepomuceno, E. G., Peixoto, M. L. C., Lacerda, M. J., Campanharo, A. S. L. O., Takahashi, R. H. C., & Aguirre, L. A. (2021) · SN Computer Science · doi:10.1007/s42979-021-00794-3 · Cited by 16 · see citing works

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic

Barbuddhe, S. B., Rawool, D. B., Gaonkar, P. P., Vergis, J., Dhama, K., & Malik, S. V. S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1810496 · Cited by 15 · see citing works

A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials

Jeyanthi, V., Govindarajan, V. K., Sekaran, S., & Venkatapathy, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.637378 · Cited by 15 · see citing works

COVID-19 vaccinations: An overview of the Italian national health system's online communication from a citizen perspective

Pirrotta, L., Guidotti, E., Tramontani, C., Bignardelli, E., Venturi⋄, G., & Rosis, S. D. (2022) · Health Policy · doi:10.1016/j.healthpol.2022.08.001 · Cited by 15 · see citing works

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidatePreprint

Arora, K., Rastogi, R., Arora, N. M., Parashar, D., Paliwal, J., Naqvi, A., Srivastava, A., Singh, S. K., Kalyanaraman, S., Potdar, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.18.099234 · Cited by 14 · see citing works

Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults

Ntouros, P. A., Kravvariti, E., Vlachogiannis, N. I., Pappa, M. B., Trougakos, I. P., Terpos, E., Tektonidou, M. G., Souliotis, V. L., & Sfikakis, P. P. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166393 · Cited by 12 · see citing works

CoWIN: The Future of Universal Immunization Program in India

Arjun, M. C., Singh, A. K., & Parida, S. P. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_979_22 · Cited by 13 · see citing works

COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE

Niankara, I., Muqattash, R. S., Niankara, A., & Traoret, R. I. (2020) · Journal of Open Innovation Technology Market and Complexity · doi:10.3390/joitmc6040132 · Cited by 11 · see citing works

Nano COVID-19 Vaccines: the firsts RNA lipid nanoparticle vaccines being approved from history - Review

Pacheco, T. J. A., da Silva, V. C. M., & de Souza, D. G. (2020) · Research Society and Development · doi:10.33448/rsd-v9i12.11123 · Cited by 11 · see citing works

Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media

Lamptey, E., Senkyire, E. K., Serwaa, D., Aki, B. D., Boakye, E. O., Ikome, T., & Asamoah, A. (2022) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2022.11.2.193 · Cited by 11 · see citing works

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

Jawalagatti, V., Kirthika, P., Hewawaduge, C., Park, J.-Y., Yang, M., Oh, B., So, M. Y., Kim, B., & Lee, J. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.811802 · Cited by 11 · see citing works

SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in Mice

Barnwal, A., Basu, B., Tripathi, A., Soni, N., Mishra, D., Banerjee, A. K., Kumar, R., Vrati, S., & Bhattacharyya, J. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01094 · Cited by 11 · see citing works

Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital Workers

Rivera‐Izquierdo, M., Soler‐Iborte, E., de Rojas, J. P., Pegalajar‐García, M. D., Gil‐Villalba, A., Ruíz‐Villaverde, R., & Valero-Ubierna, M. D. C. (2021) · Vaccines · doi:10.3390/vaccines10010015 · Cited by 10 · see citing works

Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants

Dawood, A. A. (2022) · Vacunas · doi:10.1016/j.vacun.2022.05.006 · Cited by 8 · see citing works

Analytical Performance of a Multiplexed Microarray Assay for Rapid Identification and Quantification of a Multivalent mRNA Vaccine

Gerold, M. N., Toth, E., Blair, R. H., Gao, R. Y., Nadkarni, D. V., Barua, S., Woods, J., Rowlen, K. L., & Dawson, E. D. (2024) · Vaccines · doi:10.3390/vaccines12101144 · Cited by 8 · see citing works

Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines

Júnior, J. A. C. N., Santos, A. M., Cavalcante, R. C. M., Quintans‐Júnior, L. J., Walker, C. I. B., Borges, L. P., Frank, L. A., & Serafini, M. R. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1908343 · Cited by 8 · see citing works

Accelerating SARS-CoV-2 Vaccine Development: Leveraging Novel Hybrid Deep Learning Models and Bioinformatics Analysis for Epitope Selection and Classification

Ameen, Z. S., Mostafa, H., Ozsahin, D. U., & Mubarak, A. S. (2023) · Processes · doi:10.3390/pr11061829 · Cited by 8 · see citing works

Recent Developments in Vaccines against Flaviviruses and Alphaviruses

Kim, Y. C., & Reyes‐Sandoval, A. (2023) · Vaccines · doi:10.3390/vaccines11020448 · Cited by 6 · see citing works

The Tragedy of Liberal Democratic Governance in the Face of Global Threats

Muraille, É., Naccache, P., & Pillot, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.902724 · Cited by 6 · see citing works

Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research

Häfner, S. J. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.02.001 · Cited by 5 · see citing works

Describing mRNA Vaccine Technology for a Military Audience

Biggs, A. T., & Littlejohn, L. F. (2022) · Military Medicine · doi:10.1093/milmed/usac129 · Cited by 5 · see citing works

Intranasal Immunization with Chitosan-PLGA-rOmp22 Protects Against Multidrug-Resistant Acinetobacter baumannii-Associated Pneumonia

Yang, N., Xue, J., Zhou, R., He, Y., Zhao, Y., Zhu, C., Shao, M., Gao, N., Fan, F., Feng, G., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01049 · Cited by 4 · see citing works

“Freedom and Dignity Are Worth More than Life”: The Dramatic Suicide of an Anti-Vax Man

Sablone, S., Spagnolo, L., Macorano, E., Ciavarella, M. C., Pascale, N., Strisciullo, G., Introna, F., & Fazio, A. D. (2022) · Healthcare · doi:10.3390/healthcare10112141 · Cited by 4 · see citing works

Development of Etf-3-specific nanobodies to prevent Ehrlichia infection and LNP-mRNA delivery in cellular and murine models

Duan, N., Lin, M., Zhang, W., Yan, Q., Chien, R. C., Budachetri, K., Denton, S. L., Kawahara, J., Lakritz, J., Zhong, Y., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.128027 · Cited by 4 · see citing works

Preparatory phase for clinical trials of COVID-19 vaccine in Nepal

Gupta, G. P., Shah, Y., Pant, D. K., Lekhak, S. P., Shahi, R., Mandal, A., Poudel, P., Dumre, S. P., Pandey, K., & Pandey, B. D. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1809267 · Cited by 4 · see citing works

A Study on the Relationship between Banyuwangi Government Policy Mall Orang Sehat Mall of Health People with the Acceptance of the Coronavirus Disease 2019 Vaccine in Indonesian – Implications for Vaccination Implementation Policies

Pamungkas, A. Y. F., Trianita, D., Damayanti, F. E., Qomariyah, A., Wahyuni, L. E. T., Munif, B., & Wirawati, W. A. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.7388 · Cited by 5 · see citing works

What is the optimal country for minimum COVID-19 morbidity and mortality rates?

Arbel, Y., Arbel, Y., Kerner, A., & Kerner, M. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26632-y · Cited by 4 · see citing works

A required isolation index to support the health system during the pandemic of Covid-19 in Minas Gerais, Brazil

Versiani, A. F., de Sousa, R. G., Monteforte, P. T., Marciano, J. J. D. S., Nepomuceno, E. G., Nazaré, T. E. D., Lacerda, M. J., Barroso, M. F. S., Júnior, M. A. A., de Alvarenga, É. C., et al. (2021) · IEEE Latin America Transactions · doi:10.1109/tla.2021.9451241 · Cited by 4 · see citing works

A Hierarchy of Medical Countermeasures Against Biological Threats

Biggs, A. T., & Littlejohn, L. F. (2022) · Military Medicine · doi:10.1093/milmed/usac077 · Cited by 3 · see citing works

Viral-vectored vaccines against SARS-CoV-2

Kim, Y. C., & Reyes‐Sandoval, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90248-9.00003-6 · Cited by 2 · see citing works

Adaptive Leadership and Independent Opinions: Lessons From the National COVID-19 Immunisation Programme

Bulgiba, A. M. (2021) · Asia Pacific Journal of Public Health · doi:10.1177/10105395211065309 · Cited by 2 · see citing works

MultiPharm-DT: A Multi-Objective Decision Tool for Ligand-Based Virtual Screening Problems

Martín, S. P., Redondo, J. L., Ferrández, M. R., Pérez‐Sánchez, H., & Ortigosa, P. M. (2021) · Informatica · doi:10.15388/21-infor469 · Cited by 2 · see citing works

Engaging African diaspora in the fight against vaccine hesitancy

Ateghang-Awankem, B., & Anchang, K. Y. (2020) · American journal of public health research · doi:10.12691/ajphr-9-1-4 · Cited by 2 · see citing works

Vaccination Studies Against COVID-19 Agent: Current Status

Hıntıstan, S., & KAZAK, A. (2020) · Bezmialem Science · doi:10.14235/bas.galenos.2020.4669 · Cited by 2 · see citing works

COVID-19 vaccination status within anesthesia services: navigating uncharted waters

Goldstein, H. V., & Goldstein, J. C. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-021-01965-9 · Cited by 2 · see citing works

Infectious Disease and Epidemiology

Sattenspiel, L., & Orbann, C. (2023) · doi:10.1002/9781119828075.ch10 · Cited by 2 · see citing works

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses

Kim, Y. C., & Reyes‐Sandoval, A. (2025) · Vaccines · doi:10.3390/vaccines13080808 · Cited by 2 · see citing works

Knowledge and vaccination in COVID-19 management efficiency: a Global Malmquist-Luenberger index analysis

José, M. C. P., Márquez-Arenas, L., Povedano‐Fernández, P., Sara, R., & Gómez, J. L. Z. (2025) · Journal of Innovation & Knowledge · doi:10.1016/j.jik.2025.100867 · Cited by 1 · see citing works

Gene expression of ACE2 gene in patients infected with COVID-19 and comparing them with vaccine recipients

Mahmoud, M. A. K., & Khudhair, N. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00594 · Cited by 1 · see citing works

Immunological Interventions for the Management of Coronavirus Disease 2019 (COVID-19)

Chauhan, R. S., Malik, Y. S., Saminathan, M., & Tripathi, B. N. (2024) · Springer eBooks · doi:10.1007/978-981-99-2718-0_15 · Cited by 1 · see citing works

In search of a vaccine against COVID-19: implications for nursing practice

Boulton, J. (2020) · British Journal of Nursing · doi:10.12968/bjon.2020.29.16.948 · Cited by 1 · see citing works

Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants

Dawood, A. A. (2022) · Vacunas (English Edition) · doi:10.1016/j.vacune.2022.10.012 · Cited by 1 · see citing works

El sendero hacia la vacuna contra SARS-CoV-2

Marín, J. E. O. (2020) · ALERTA Revista Científica del Instituto Nacional de Salud · doi:10.5377/alerta.v3i2.9749

Making Pandora’s Box: The Politics of Science Funding

Allard, G. (2020) · TigerPrints (Clemson University)

Immunobiochemical Aspects in the Pathogenesis, Diagnosis, and Management of Novel Coronavirus (SARS-Cov-2) InfectionPreprint

Pinnelli, V. B. K., Sirsikar, M., Vandana, W. V., Mohanty, S., Wilma Delphine Silvia, C. R., Mohapatra, R. K., Vadakedath, S., & Kandi, V. (2020) · Preprints.org · doi:10.20944/preprints202009.0565.v1

Genomic Variation and Treatment Strategies of COVID-19: A Descriptive Review

Kundu, S., & Singh, S. (2021) · The Open COVID Journal · doi:10.2174/2666958702101010006

A novel coronavirus—from basic research to clinic

Luo, D., Wang, T., Tan, Z., Guo, S., Yu, Z., Liu, Y., ZHANG, Y., Wang, B., Gao, Y., Wang, H., et al. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2020-0233

Development of first Generation COVID-19 Vaccines: State-of the-Art Technologies and future Implications!

Mweetwa, L. L., Tlhoiwe, D., Tlhoiwe, T., Tshiamo, K. O., Munsaka, S. M., Kenaope, T. J., Mothibe, G., Mokate, O., & Oluwabusola, E. T. (2022) · Medical Research Archives · doi:10.18103/mra.v10i9.3027

The rapid progress in COVID vaccine development and implementation

Barrett, A. D. T., Titball, R. W., MacAry, P. A., Rupp, R. E., von Messling, V., Walker, D. H., & Fanget, N. V. J. (2022) · npj Vaccines · doi:10.1038/s41541-022-00442-8 · Cited by 35 · see citing works

COVID‐19: vaccine’s progress

Brüssow, H. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13818 · Cited by 19 · see citing works

Recombinant Vaccines: The Revolution Ahead

Nayak, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_8

Vaccine Development Throughout History

Saleh, A., Qamar, S., Tekin, A., Singh, R., & Kashyap, R. (2021) · Cureus · doi:10.7759/cureus.16635 · Cited by 86 · see citing works